← All organizations

Tigermed Consulting Co., Ltd

For profitWebsite ↗

Also known as: TigerMed | TIGERMED AUSTRALIA PTY LIMITED | Tigermed Consulting Co., Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Jun 1, 2026

Timeline

2000s

Dec 15, 2004
Tigermed Consulting Co., Ltd— Founded

2010s

May 8, 2014
Frontage Laboratories, Inc.— Acquired
Oct 1, 2015
DreamCIS— Acquired
Jan 8, 2019
mycophenolate— Marketing Organization

Drugs by trial phase (53 distinct, 50 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (12 own, 1 via acquisition)

Phase 2 (9 own, 4 via acquisition)

Phase 1 (6 own, 17 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 5 total across the full acquisition tree)

Recent trials (30)

NCT06666335CollaboratorPhase 4Oct 30, 2024
NCT06564194CollaboratorPhase 1Sep 25, 2024
NCT06581575CollaboratorPhase 2Sep 20, 2024
NCT06081465CollaboratorPhase 1Oct 31, 2023
NCT06114329CollaboratorPhase 2Oct 25, 2023
NCT05885763CollaboratorPhase 1Jun 26, 2023
NCT05885737CollaboratorPhase 3May 30, 2023
NCT05498597CollaboratorPhase 1Dec 20, 2022
NCT05484466CollaboratorPhase 2Nov 15, 2022
NCT05388487CollaboratorPhase 1Feb 16, 2022
NCT05136664CollaboratorPhase 3Dec 31, 2021
NCT05177926CollaboratorPhase 4Apr 4, 2021
NCT04629131CollaboratorPhase 1Nov 25, 2020
NCT04370431CollaboratorPhase 1Apr 24, 2020
NCT03520972CollaboratorPhase 2May 7, 2018

Details

Founded: Hangzhou, CN Dec 15, 2004
Last known activity: Jun 1, 2026